AstraZeneca plc (ADR) (AZN): Is It The Ultimate Stock Picker’s Share?

Few companies have a record of paying a dividend of such size. Another factor to attract investors is the fact that AstraZeneca has not cut its dividend in more than ten years.

By my calculations, only Shell is currently cheaper on both a P/E and yield basis.

Strong share price
Many investors won’t buy unless they see some signs of share price revival. So far this year, AstraZeneca plc (ADR) (NYSE:AZN) shares are up 14.1%. That’s well ahead of the FTSE 100, which is up 9% in the same period. This upturn in AstraZeneca’s share price means that the shares have now come to the attention of momentum investors.

Momentum investors believe that a company’s shares are more likely to rise if they have some gains behind them. For AstraZeneca plc (ADR) (NYSE:AZN) to get back to the kind of rating enjoyed by the average FTSE 100 company, the shares would need to rise more than 30%.

The article Is AstraZeneca the Ultimate Stock Picker’s Share? originally appeared on Fool.com.

David O’Hara has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.